ZSP1603

· Guangdong Raynovent Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZSP1603, covering 2025-03-19 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF） [Phase 1, Phase 2]

See pricing